Kamala Harris trashed pro-life Americans on Friday, calling them “extremists” and defending abortion as a “fundamental freedom.”

Harris met with leaders from the nation’s most aggressively pro-abortion groups, includ9ing Planned Parenthood and NARAL, to promote killing more babies with the dangerous abortion pill. During the meeting, Harris claims pro-life Americans who want to protect babies from abortions are “extremists” who oppose health care even though killing a baby and injuring women in abortions is the opposite of health care.

“This is not just an attack on women’s fundamental freedoms. It is an attack on the very foundation of our public health system,” Harris said.

Harris ignores the fact that ending the life of an unborn baby in an abortion denies their fundamental freedom of the right to life that the Constitution protects for everyone.

Harris also ignores how abortion hurt women and how the abortion pill she’s promoting is burdening the public health system because emergency rooms across the country are being flooded by women victimized by the dangerous abortion pill. In fact, the abortion pill mifepristone is so dangerous for women that ER visits have skyrocketed 500%.

Ironically, Harris’ meeting to promote the abortion drug further comes just weeks after news that the abortion pill killed a woman in Canada.

Research showing the increased serious risks associated with mifepristone, including a first-of-its-kind longitudinal study, published in November 2021 that found the rate of abortion-related emergency room visits following a chemical abortion increased by more than 500 percent from 2002 through 2015.

SUPPORT LIFENEWS! To help us stand against Joe Biden’s abortion agenda, please help LifeNews.com with a donation!

Growing evidence shows that the abortion drug is certainly not safer than Tylenol, as the pro-abortion movement and some news outlets claim. A study from the pro-abortion research group Gynuity provides evidence that the claim is false.

Live Action News analyzed the study, published in the journal “Contraception,” and confirmed that it disproves the popular safety claim. The Gynuity study “found an ER and urgent care visit rate of 6%” for women taking the abortion drug, which is “107 times greater than the rate for acetaminophen/Tylenol,” according to the report.

Millions of unborn babies have been killed with the abortion drug mifepristone, or RU-486, since its approval under the Clinton administration. Currently, it is used for almost half of all abortions in the U.S., according to the Guttmacher Institute.

Other studies also indicate the risks of mifepristone are more common than what abortion activists often claim, with as many as one in 17 women requiring hospital treatment. A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.

Another new study from the University of Toronto, “Short-Term Adverse Outcomes After Mifepristone–Misoprostol Versus Procedural Induced Abortion,” published in the Annals of Internal Medicine, found that one in ten women who took the abortion pill had to go to the emergency room, according to Pregnancy Help News.

Similarly, a 2009 study “Immediate Complications After Medical Compared With Surgical Termination of Pregnancy,” in “Obstetrics and Gynecology” found a complication rate of approximately 20 percent for the abortion drugs compared to 5.6 percent for surgical abortions. Hemorrhages and incomplete abortions were among the most common complications.

Along with millions of unborn babies’ deaths, the FDA has linked mifepristone to at least 28 women’s deaths and 4,000 serious complications. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.

The post Kamala Harris Calls Pro-Life Americans “Extremists,” Says Killing Babies in Abortion is a “Fundamental Freedom” appeared first on LifeNews.com.

Leave a Reply